|
Session 132
Poster Abstracts
Switching Therapy/Treatment Failure in Scale-up Programs
Tuesday, 1-4 pm
Room: Hall B |
| 831 |
Lopinavir/Ritonavir (LPV/r) + 2 Nucleoside Analogues as Second-line ART in Protease Inhibitor-naïve Adults in South Africa: Outcomes and Adverse Effects
Richard Murphy*1, H Sunpath2, A Nijhawan3, M McLellan1, and D Kuritzkes1
1Brigham and Women`s Hosp, Boston, MA, US; 2McCord Hosp, Durban, South Africa; and 3Brown Univ Med Sch and Miriam Hosp, Providence, RI, US |
| 832 |
Immunological Response to Boosted PI-containing Second-line ART after Switching for Clinical/immunological Criteria Is Comparable to Response to First-line in Patients with Low CD4 Counts in Africa
Cleophas Chimbetete*1, C Kityo2, P Munderi3, A Walker4, A Reid1, F Ssali2, H Grosskurth3, J Darbyshire4, C Gilks5, and Dart TRial
1Univ of Zimbabwe, Harare; 2Joint Clin Res Ctr, Kampala, Uganda; 3Med Res Council/Uganda Virus Res Inst Prgm on AIDS, Entebbe, Uganda; 4Med Res Council Clinical Trials Unit, London, UK; and 5Imperial Coll London, UK |
| 833 |
Clinical and Immunologic Correlates of Mortality and Virologic Failure among HIV-infected Individuals Receiving ART >90 Days in Rural Uganda
David Moore*1,2,3, S Malamba1, J Tappero1, W Were1, R Degerman1, R Downing1, and J Mermin1
1Global AIDS Prgm, CDC Uganda, Entebbe; 2BC Ctr for Excellence in HIV/AIDS, Vancouver, Canada; and 3Univ of British Columbia, Vancouver, Canada |
| 834 |
Immunological Monitoring as an Indicator of Virological Failure May Lead to Premature Switch to Second-line ART Regimens
Rami Kantor*1, L Diero2, A DeLong1, W Emonyi2, S Kimaiyo2, P Chan1, J Carter1, and N Buziba2
1Brown Univ, Providence, RI, US and 2Moi Univ, Eldoret, Kenya |
| 835 |
Probability and Predictors of Survival, Drop-out, or Switch to a WHO Standard Second-line ART Regimen in Resource-limited Settings with Viral Load Monitoring Availability: The DREAM Program
M Marazzi1, L Palombi2, G Guidotti3, P Germano4, G Tintisona4, M Magnano San Lio4, and Andrea De Luca*5
1Libera Univ Maria SS Assunta, Rome, Italy; 2Univ of Tor Vergata, Rome, Italy; 3Inst Superiore di Sanita, Rome, Italy; 4DREAM Prgm, Community of St Egidio, Italy; and 5Catholic Univ, Rome, Italy |
| 836 |
Botswana's ART Failure Management: A 5-Year Review of the Infectious Disease Care Clinic at Princess Marina Hospital
Ava Avalos*1, T Gaolathe2, S Cloutier1, N Ndwapi1, F Doualla-Bell3, M Mosepele4, M Zwanila1, H Moffat4, K Seipone4, and M Wainberg3
1Botswana Ministry of Hlth; 2Botswana Harvard Sch of Publ Hlth AIDS Initiative Partnership for HIV Res and Ed, Gaborone; 3McGill Univ AIDS Ctr, Montreal, Canada; and 4Princess Marina Hosp, Gaborone, Botswana |
| 837 |
Effectiveness and Safety of Generic Second-line PI-based ART in Western India
Sanjay Pujari*1,2, A Dravid3, N Gupte4, A Dhananjay3, M Lynette2, and J Sinnott2
1Inst of Infectious Diseases, Pune, India; 2Univ of Tampa, FL, US; 3Inst of Infectious Diseases, Pune, India; and 4Consultant Biostatistician |
|
